Results 161 to 170 of about 305,336 (311)
Fetal echocardiography: A nine-year experience at a single tertiary center. [PDF]
Tosun O.
europepmc +1 more source
Transoesophageal echocardiography [PDF]
Partho P, Sengupta, Bijoy K, Khandheria
openaire +2 more sources
Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats
Parts of the figure were drawn by using pictures from Servier Medical Art. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/). Abstract Aims Sacubitril/valsartan (Sac/Val) is used for treatment of heart failure. The effect of Sac/Val on regional dysfunction
Einar Sjaastad Nordén +16 more
wiley +1 more source
Multimodality imaging in hypertrophic cardiomyopathy. [PDF]
Kim J, Lee SC.
europepmc +1 more source
Abstract Objective This study aimed to evaluate the utility of left atrial volume and function in uraemic patients using four‐dimensional automatic left atrial quantification (4D auto LAQ) technology. Methods Thirty‐four undialysed uraemic patients (U‐ND group), 60 dialysed uraemic patients (U‐D group), and 32 healthy volunteers (N group) were enrolled
Bing Li, Meihua Chen, Xuning Huang
wiley +1 more source
Real-time deep learning-based image guiding and automated left ventricular measurements to reduce test-retest variability. [PDF]
Pettersen H +10 more
europepmc +1 more source
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer +25 more
wiley +1 more source
Prehospital transesophageal echocardiography during cardiac arrest: feasibility confirmed, but clinical interpretation must remain anchored to resuscitation fundamentals. [PDF]
Hung MH, Yeh TY.
europepmc +1 more source
Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen +7 more
wiley +1 more source

